Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat

被引:108
作者
Chiavegato, Angela
Bollini, Sveva
Pozzobon, Michela
Callegari, Andrea
Gasparotto, Lisa
Taiani, Jenny
Piccoli, Martina
Lenzini, Elisabetta
Gerosa, Gino
Vendramin, Igor
Cozzi, Ernanuele
Angelini, Annalisa
Iop, Laura
Zanon, Giovanni F.
Atala, Anthony
De Coppi, Paolo
Sartore, Saverio
机构
[1] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy
[2] Univ Padua, Dept Pediat, Padua, Italy
[3] Dept Cardiol Thorac & Vasc Sci, Padua, Italy
[4] Dept Med & Surg Sci, Padua, Italy
[5] Inst Pathol Anat, Padua, Italy
[6] Div Pediat Surg, Padua, Italy
[7] Wake Forest Univ, Sch Med, Med Ctr, Winston Salem, NC 27109 USA
[8] Great Ormond St Hosp Sick Children, Surg Unit, London WC1N 1EH, England
[9] UCL, Inst Child Hlth, London WC1N 1EH, England
关键词
myocardial ischemia; stem cells; cell therapy; xenotransplantation; immune rejection;
D O I
10.1016/j.yjmcc.2006.12.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human amniotic fluid-derived stem (AFS) cells, similarly to embryonic stem cells, could possess privileged immunological characteristics suitable for a successful transplantation even in a discordant xenograft system. We investigated whether AFS cells could be fruitfully used in a rat model of myocardial infarction. c-kit immunomagnetic-sorted AFS cells were characterized by flow cytometric analysis and cytospins as well as reverse-transcription polymerase chain reaction, Western blotting and immunocytochemistry for cardiovascular differentiation markers. In vitro, AFS cell phenotypic conversion was assayed by cardiovascular-specific induction media or co-cultured with rat neonatal cardiomyocytes. AFS cells showed mRNAs and/or protein for endothelial (angiopoietin, CD146) and smooth muscle (smoothelin) cells, and cardiomyocyte (Nkx2.5, MLC-2v, GATA-4, beta-MyHC) markers. Acquisition of a cardiomyocyte-like phenotype in rare AFS cells could be seen only in co-cultures with rat neonatal cells. In vivo, AFS cells xenotransplantated in a rat model of myocardial infarction, with or without cyclosporine treatment, or in intact heart from immuno-competent or immuno-deficient animals were acutely rejected due to the different recruitment of recipient CD4(+), CD8(+) T and B lymphocytes, NK cells and macrophages. This reaction is most likely to be linked to expression of B7 co-stimulatory molecules CD80 and CD86 as well as macrophage marker CD68 on AFS cells. Xenotransplanted AFS cells gave also rise in some animals to cell masses in the subendocardium and myocardium suggestive of a process of chondro-osteogenic differentiation. Despite AFS cells in vitro can differentiate to some extent to cells of cardiovascular lineages, their in vivo use in xenotransplantation for cell therapy of myocardial infarction is hampered by their peculiar immunogenic properties and phenotypic instability. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:746 / 759
页数:14
相关论文
共 36 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]   Engraftment potential of human amnion and chorion cells derived from term placenta [J].
Bailo, M ;
Soncini, M ;
Vertua, E ;
Signoroni, PB ;
Sanzone, S ;
Lombardi, G ;
Arienti, D ;
Calamani, F ;
Zatti, D ;
Paul, P ;
Albertini, A ;
Zorzi, F ;
Cavagnini, A ;
Candotti, F ;
Wengler, GS ;
Parolini, O .
TRANSPLANTATION, 2004, 78 (10) :1439-1448
[3]   NONMUSCLE AND SMOOTH-MUSCLE MYOSIN ISOFORMS IN BOVINE ENDOTHELIAL-CELLS [J].
BORRIONE, AC ;
ZANELLATO, AMC ;
GIURIATO, L ;
SCANNAPIECO, G ;
PAULETTO, P ;
SARTORE, S .
EXPERIMENTAL CELL RESEARCH, 1990, 190 (01) :1-10
[4]   Immunocytological evidence for hematopoiesis in the early human placenta [J].
Challier, JC ;
Galtier, M ;
Cortez, A ;
Bintein, T ;
Rabreau, M ;
Uzan, S .
PLACENTA, 2005, 26 (04) :282-288
[5]   Can stem cells mend a broken heart? [J].
Davani, S ;
Deschaseaux, F ;
Chalmers, D ;
Tiberghien, P ;
Kantelip, JP .
CARDIOVASCULAR RESEARCH, 2005, 65 (02) :305-316
[6]  
De Coppi P., 2001, AM AC PED NAT C SAN, P210
[7]   Isolation of amniotic stem cell lines with potential for therapy [J].
De Coppi, Paolo ;
Bartsch, Georg, Jr. ;
Siddiqui, M. Minhaj ;
Xu, Tao ;
Santos, Cesar C. ;
Perin, Laura ;
Mostoslavsky, Gustavo ;
Serre, Angeline C. ;
Snyder, Evan Y. ;
Yoo, James J. ;
Furth, Mark E. ;
Soker, Shay ;
Atala, Anthony .
NATURE BIOTECHNOLOGY, 2007, 25 (01) :100-106
[8]   Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells [J].
Drukker, Micha ;
Katchman, Helena ;
Katz, Gil ;
Friedman, Smadar Even-Tov ;
Shezen, Elias ;
Hornstein, Eran ;
Mandelboim, Ofer ;
Reisner, Yair ;
Benvenisty, Nissim .
STEM CELLS, 2006, 24 (02) :221-229
[9]  
du Toit D, 1998, MICROSC RES TECHNIQ, V43, P347, DOI 10.1002/(SICI)1097-0029(19981115)43:4<347::AID-JEMT9>3.3.CO
[10]  
2-F